RecruitingPhase 2NCT05551793

Regeneron AA Multicenter (Dupilumab)

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emma Guttman
Principal Investigator
Emma Guttman-Yassky, MD, PhD
Icahn School of Medicine at Mount Sinai
Intervention
Dupilumab(drug)
Enrollment
68 target
Eligibility
18 years · All sexes
Timeline
20232027

Study locations (3)

Collaborators

Regeneron Pharmaceuticals

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05551793 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials